Microscopy System analyzes multi-scale and multi-modal images.

Press Release Summary:




Consisting of hardware and software package, ZEISS Atlas 5 extends capacity of SEMs and FIB-SEMs. System streamlines automatic image acquisition, enabling navigation and correlation of images from any source including light and X-ray microscopes. Users can acquire large sets of 2D or 3D microscope images for hours, or even days, without operator supervision. Correlative workspace brings together images from multiple sources: zooming in from full macroscopic view down to nanoscale details.



Original Press Release:



ZEISS Atlas 5 - a New Approach to Master the Multi-scale Challenge



ZEISS introduces an integrated solution to acquire and analyze multi-scale and multi-modal images in light, electron and X-ray microscopy



Jena/Germany, Portland/USA, -- ZEISS Atlas 5 is a powerful hardware and software package that extends the capacity of ZEISS scanning electron microscopes (SEM) and focused ion beam SEMs (FIB-SEM). ZEISS Atlas 5 streamlines automatic image acquisition and lets users benefit from its efficient navigation and correlation of images from any source including light and X-ray microscopes.



Taking  full advantage of high throughput and automated large area imaging, users acquire large sets of 2D or 3D nanoscale electron microscope (EM) images for hours, or even days, without operator supervision. Advanced preset and customizable protocols allow to produce consistent and reproducible results.



ZEISS Atlas 5 correlative workspace makes it easy to bring together images from multiple sources: zooming in from the full macroscopic view of the sample down to nanoscale details. The sample-centric workspace lets users build a seamless multi-modal, multi-scale picture of the sample.



The novel graphical user interface concept of ZEISS Atlas 5 makes it easy to investigate all samples. Users design a workflow tailored precisely to the complexity of their experiments, no matter whether it’s a simple one-step task or a compound experiment. A sophisticated workflow environment guides the user all the way from the setup for automated acquisition to post-processing and customized exports, and right on through to analysis.



The modular structure of ZEISS Atlas 5 allows users to tailor it to their everyday tasks in materials or life sciences applications. The package comes with multiple modules: Advanced Toolkit, 3D Tomography, Array Tomography or Advanced Nanopatterning & Visualization Engine (NPVE Advanced).



Press contact

Microscopy

Dr. Jochen Tham

Phone +49 3641 64-3949

Email: jochen.tham@zeiss.com

www.zeiss.com/press



About ZEISS

ZEISS is an internationally leading technology enterprise operating in the optics and optoelectronics industries. ZEISS develops and distributes lithography optics, measuring technology, microscopes, medical technology, eyeglass lenses, camera and cine lenses, binoculars and planetarium technology. With its solutions, the company constantly advances the world of optics and helps shape technological progress. The company is divided up into the six business groups Industrial Metrology, Microscopy, Medical Technology, Vision Care, Consumer Optics and Semiconductor Manufacturing Technology. ZEISS is represented in over 40 countries – with around 30 production sites, over 50 sales and service locations and about 25 research and development facilities. In fiscal year 2013/14 the company generated revenue approximating 4.3 billion euros with just under 25,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).



Further information at www.zeiss.com



Microscopy

The Microscopy business group is the world's only one-stop manufacturer of light, X-ray and electron microscope systems. The portfolio includes solutions and services both for life sciences and materials research and for industry, education and clinical practice. The business group is headquartered in Jena. Additional production and development sites are located in Oberkochen, Göttingen and Munich in Germany, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. The business group employs a total of over 3,000 people. It generated revenue of 656 million euros in fiscal year 2013/14.

All Topics